DAVID NEWMAN

Patient centered reforms of the Pharmacy Benefit Manager industry and Most Favored Nation policies

Patient centered reforms of the Pharmacy Benefit Manager industry and Most Favored Nation policies

Patient centered reforms of the Pharmacy Benefit Manager industry and the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, Concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry, Concerns with the Inflation Reduction Act

Patient centered reforms of the Pharmacy Benefit Manager industry

PDUFA reauthorization

Advocacy to protect patient access

PDUFA reauthorization

Advocacy to protect patient access

HR3 Lower Drug Cost legislation, advocacy to protect patient access

HR3 Lower Drug Cost legislation, advocacy to protect patient access

HR3 Lower Drug Cost legislation, advocacy to protect patient access

Prescription drug coverage, biopharma innovation

HR3 Lower Drug Costs Now Act

Maintain coverage of Medicare's Six Protected Classes

Most Favored Nation/International Pricing Index

Most Favored Nation/International Pricing Index

Notice of Benefit and Payment Parameters

Rebate Reform, International Pricing Index

Rebate Reform, International Pricing Index

USMCA

Rebate Reform, International Pricing Index

Rebate Reform, International Pricing Index

6 Protected Classes and Rebate Reform

Medicare Part D, Medicare Part B

Medicare Part D

Medicare Part B, Medicare Part D

Independent Payment Advisory Board, Centers for Medicare & Medicaid Services, Children's Health Insurance Program

NIH Funding

Importation

Independent Payment Advisory Board, Centers for Medicare & Medicaid Services

Independent Payment Advisory Board, Centers for Medicare & Medicaid Services, Part D Low Income Subsidy

Re-authorization of the Prescription Drug User Fee Act

Importation, Independent Payment Advisory Board

Re-authorization of the Prescription Drug User Fee Act

Importation

NIH Funding

NIH Funding

Medicare Part D and Part B

NIH Funding

Medicare Part D and Part B

Medicare Part D and Part B

NIH Funding

Advocate for sustainable reforms to the 340B Pharmacy Program

Medicare Part D and Part B

NIH Funding

Medicare Part D

340B Pharmacy Program

NIH Funding

NIH Funding

Medicare Part D and the Independent Payment Advisory Board

340B Pharmacy Program.

NIH Funding

Medicare Part D and the Independent Payment Advisory Board

340B Pharmacy Program.

Medicare Part D and the Independent Payment Advisory Board

NIH Funding

340B Pharmacy Program.

Medicare Part D, 340B Pharmacy, Patent Reform, IPAB, NIH funding

Medicare Part D, 340B Pharmacy, Patent Reform, IPAB, NIH funding

Medicare Part D, 340B Pharmacy, Patent Reform, IPAB, NIH funding